⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2465534 | 1.00 | — | — | |
| SCHEMBL1891164 | 0.76 | — | — | |
| SCHEMBL1891166 | 0.76 | — | — | |
| SCHEMBL4600151 | 0.73 | — | — | |
| SCHEMBL4600148 | 0.73 | — | — | |
| SCHEMBL8337353 | 0.73 | — | — | |
| SCHEMBL4600156 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL28002765 | 0.73 | — | — | |
| SCHEMBL4459656 | 0.72 | — | — | |
| SCHEMBL13936166 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2547334-B1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | 1GLOBE BIOMEDICAL CO LTD (CN) | 2017-11-15 | — | — | EP | claimed |
| US-20130034591-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | BOSTON BIOMEDICAL, INC. (US) | 2013-02-07 | — | — | US | claimed |
| EP-2547334-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | Boston Biomedical, Inc. (US) | 2013-01-23 | — | — | EP | claimed |
| WO-2011116398-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | BOSTON BIOMEDICAL, INC. (US) | 2011-09-22 | — | — | WO | claimed |
| EP-3108750-B1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | 1GLOBE BIOMEDICAL CO LTD (CN) | 2018-07-04 | — | — | EP | disclosed |
| EP-3295796-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | 1Globe Biomedical Co., Ltd. (CN) | 2018-03-21 | — | — | EP | disclosed |
| EP-3108750-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | Boston Biomedical, Inc. (US) | 2016-12-28 | — | — | EP | disclosed |
| US-20090048461-A1 | Regulators of Bacterial Signalling Pathways | BIOSIGNAL LIMITED (AU) | 2009-02-19 | — | — | US | disclosed |